Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Intravenous Tranexamic Acid in Reducing Blood Loss in Spinal Surgeries
IRCT20230519058227N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Herniated Lumbar Disk, lumbar spinal stenosis (LSS), spondylolisthesis and 3 more, sponsored by Alborz University of Medical Sciences. Started Aug 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Herniated Lumbar Disklumbar spinal stenosis (LSS)spondylolisthesisscoliosishyperlordosis
Beyond the preview
Go deeper on IRCT20230519058227N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230519058227N1.